Mesenchymal stromal (stem) cells suppress pro-inflammatory cytokine production but fail to improve survival in experimental staphylococcal toxic shock syndrome

Overview of attention for article published in BMC Immunology, January 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

twitter: 1 X user

patent: 2 patents

Citations

dimensions_citation: 37 Dimensions

Readers on

mendeley: 51 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

MESENCHYMAL STEM CELLS FROM WHARTON'S JELLY FOR TREATING SEPSIS

Application EP-4091618-A1

European Patent Office

MESENCHYMAL STEM CELLS OBTAINED FROM WHARTON'S JELLY FOR THE TREATMENT OF SEPSIS

Application WO-2018158542-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.